The current study measures C-11-N Methylspiperone binding to these dopamine receptors using a simple, dual detector system and to monitor this in control populations for reproducibility and in selected populations of psychiatric patients who will undergo treatment with neuroleptic medications, such as haloperidol.
NIH ExPorter
NIH ExPorter